Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
90.14 EUR | +0.16% | -0.46% | +0.42% |
05-21 | Sanofi Partners with Microsoft-Backed OpenAI, Formation Bio to Develop Drugs with AI | MT |
05-21 | Sanofi: cooperation with Formation Bio and OpenAI | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.42% | 122B | |
+37.78% | 723B | |
+31.46% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.42% | 244B | |
-4.58% | 208B | |
+10.23% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Regeneron, Sanofi Receive Marketing, Production Authorization for Dupixent From Japan to Treat Chronic Spontaneous Urticaria